
FDA authorizes second COVID antiviral pill, from Merck, if no alternatives available
CBSN
The Food and Drug Administration announced Thursday it had authorized molnupiravir, a drug produced by Merck and Ridgeback Biotherapeutics, to treat some American adults with COVID-19 who are at risk of severe disease when no other options are available. The pills are meant to be started within five days of developing the first symptoms.
"Molnupiravir is limited to situations where other FDA-authorized treatments for COVID-19 are inaccessible or are not clinically appropriate and will be a useful treatment option for some patients with COVID-19 at high risk of hospitalization or death," said the FDA's Dr. Patrizia Cavazzoni.
The agency's move marks the second emergency authorization for an antiviral pill to treat COVID-19 in as many days, after the FDA greenlighted Pfizer's Paxlovid on Wednesday. It comes ahead of a feared surge that could overwhelm hospitals as the Omicron variant rapidly spreads.

Santa Fe, New Mexico — A representative for the estate of actor Gene Hackman is seeking to block the public release of autopsy and investigative reports, especially photographs and police body-camera video related to the recent deaths of Hackman and wife Betsy Arakawa after their partially mummified bodies were discovered at their New Mexico home in February.

In the past year, over 135 million passengers traveled to the U.S. from other countries. To infectious disease experts, that represents 135 million chances for an outbreak to begin. To identify and stop the next potential pandemic, government disease detectives have been discreetly searching for viral pathogens in wastewater from airplanes. Experts are worried that these efforts may not be enough.